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tuberculosis: a cross sectional study from a
national referral hospital in Uganda
Davis Kibirige1,5*†, Edrisa Mutebi1,2†, Richard Ssekitoleko1,3†, William Worodria1,4† and Harriet Mayanja-Kizza1†Abstract
Background: Vitamin D deficiency has been reported among patients with tuberculosis in Africa despite abundant
sunshine. Vitamin D plays a fundamental role in improving anti tuberculosis immunity, reducing progression and
severity of TB in humans.
Methods: In this descriptive cross sectional study, 260 hospitalized adults with a confirmed diagnosis of TB were
enrolled into the study from the pulmonology wards of Mulago national referral and teaching hospital, Uganda.
The serum concentrations of 25-hydroxyvitamin D or 25 (OH) D were determined by an electrochemilumniscence
immunoassay. Vitamin D deficiency, vitamin D insufficiency, severe and very severe vitamin D deficiency were
defined as serum 25(OH) D concentrations of ≤ 20 ng/ml, 21–29 ng/ml, < 10 ng/ml and <5 ng/ml respectively.
Results: Majority of the study participants were males (146, 56.2%) and < 35 years (154, 59.2%). The mean age ± SD
was 34.7 ± 9.5 years. Two hundred eight (80%) patients were HIV co-infected with a median CD4 count of 68 cells/mm3
(IQR: 17–165). The prevalence of vitamin D deficiency, vitamin D insufficiency, severe and very severe vitamin D
deficiency among the hospitalized adult tuberculosis patients was 44.2%, 23.5%, 13.5% and 4.2% respectively. The
median (IQR) vitamin D concentration in ng/ml was 22.55 (14.59-33.31).
Vitamin D deficiency was more prevalent in patients with hypoalbuminemia (97.4%), anemia (86.1%), HIV co-infected
patients with CD4 count <200cells/mm3 (83.2%) and hypocalcemia corrected for serum albumin levels (67%).
Conclusion: Vitamin D deficiency is very common among hospitalized adult tuberculosis patients in Uganda
especially in patients with hypoalbuminemia, anemia, HIV co-infected patients with CD4 count <200cells/mm3 and
hypocalcemia corrected for serum albumin levels.
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Uganda has one of the highest burdens of tuberculosis
(TB) in the world with an estimated TB prevalence rate
of 193/100,000 in 2010 [1]. It is estimated that 1 billion
people worldwide have either vitamin D insufficiency or
deficiency [2]. Vitamin D deficiency has been widely
documented among African immigrants in Europe [3,4]
and African TB patients [5-9]. Currently, there is adequate* Correspondence: davouirek@yahoo.co.uk
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reproduction in any medium, provided the orevidence to suggest that vitamin D deficiency is highly as-
sociated with TB [10].
The earliest study assessing the concentrations of serum
vitamin D among TB patients in Africa was done by Davies
et al. among Kenyan subjects in 1987. Lower concentra-
tions were noted among patients with untreated pulmon-
ary TB compared to the healthy controls [11]. Ensuing
studies among African TB patients done in Uganda [5],
Guinea Bissau [6], Malawi [7], Tanzania [8] and South
Africa [9] have reported similar findings with the docu-
mented prevalence of vitamin D deficiency ranging from
8.5% in Guinea Bissau [6] to 62.7% in South Africa [9].
This study aimed to determine the prevalence of vita-
min D deficiency and associated clinical factors amongLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of Mulago hospital in Kampala, Uganda.
Methods
Study design and patient population
This was a descriptive cross sectional study conducted
on the pulmonology wards of Mulago national referral
and teaching hospital in Kampala, the capital city of
Uganda. Uganda lies in the tropics with constant sunshine
all year round and very short rainy seasons. Kampala city is
located near the equator at latitude of 00°20´North. The
hospital serves a population from predominantly urban
and peri-urban areas.
Eligible consenting adults with a newly confirmed
diagnosis of TB were consecutively enrolled during the
study period of September 2011 up to February 2012
(Figure 1). A confirmed diagnosis of TB was made in pa-
tients who presented with clinical symptoms suggestive
of TB and at least one of the following: a positive sputum
smear on Ziehl Nielsen or flourochrome (Auramine-O)
stain for acid fast bacilli (AFB), a positive Xpert/RIF-TB
test result, a positive sputum culture for TB, a positive
Ziehl Nielsen stain or flourochrome (Auramine-O) stain
for AFB on fine needle lymph node aspirate and a histo-
logical diagnosis of TB on lymph node or pleural biopsy.
We excluded patients that had been taking anti TB drugs
for ≥2 weeks.
These patients were classified as having pulmonary TB
(PTB) or extra pulmonary TB (EPTB) and newly diag-
nosed TB or TB relapse at recruitment. All enrolled pa-
tients were screened for HIV.
Data collection
After obtaining informed consent, pre-tested question-
naires were used to collect information about the socio-
demographic data, medical and drug history including
use of steroids, multi vitamin supplementation, anti-
convulsants and highly active anti retro viral therapy,
karnofsky score and the laboratory variables of all the335 patients with confirmed 
TB screened.
260 eligible patients with 
confirmed TB were enrolled.
75 patients excluded:
-40 patients were on 
anti TBs > 2 weeks.
-20 patients unable to 
provide informed
consent.
-15 patients declined 
to be enrolled.
Figure 1 Study screening and enrolment chart.enrolled study participants. All participants also under-
went baseline anthropometric measurements of weight
and height for calculation of the body mass index (BMI).
Prior to initiation of anti TB treatment, blood was
drawn for measurement of the serum 25(OH) D concen-
trations, complete blood count, CD4 count, serum albu-
min and calcium concentrations, HIV serology testing,
renal function tests (serum urea and creatinine) and liver
function tests (alanine transaminase (ALT) and alkaline
phosphatase (ALP) concentrations).
Laboratory analysis
Blood was obtained from the consented study partici-
pants and immediately transported to the clinical chem-
istry and haematology laboratories of Mulago hospital.
HIV screening was done using the Determine Rapid
HIV-1/2 assay (Abbott Laboratories, Abbott Park, IL,
USA), HIV-1/2 STAT-PAK Dipstick assay (Chembio
Diagnostic Systems Inc, New York, NY, USA) and Uni-
Gold assay. The collected blood samples were centrifuged
and the extracted plasma was stored at −20°C. The analysis
was done using a full automated COBAS® integra 400
(Roche Diagnostics GmbH) machine.
The serum 25 (OH) D concentrations were deter-
mined by an immunoassay technique using the Elecsys
vitamin D3 assay. It is an electrochemilumniscence im-
munoassay supplied by Roche diagnostics. It measures
the serum 25 (OH) D concentrations in the range of 4–
100 ng/ml. Its intra-assay and inter-assay CV was 4.1%-
5.7% and 6.6%-9.9% respectively.
The formula below was used in correcting serum cal-
cium concentrations for the albumin levels. Normal serum
albumin concentration was defined as a level of 40 g/L.
Corrected calcium concentration = 0.8 (normal albumin−
patient’s albumin) + serum calcium in mg/dl [12].
Statistical analysis
Data was entered into an access data base, FoxPro for
windows (Version 2.6; Microsoft) and Stata software,
version 12.1 was used for all statistical analysis. Patient
characteristics were reported as frequency and percent-
age for categorical variables, mean and standard deviation
(SD) for the normally distributed continuous variables and
median and inter-quartile range (IQR) for continuous vari-
ables which were not normally distributed.
Based on a sample size of 146 obtained using the
prevalence of vitamin D deficiency among pulmonary
TB subjects in a Tanzanian study of 10.6% [8] with 80%
power and a 2-sided α < 0.05, the statistical power was
adequate to detect a medium sized effect of Tuberculosis
on Vitamin D deficiency (W of 0.165).
Vitamin D status of the study participants was de-
fined as per the Endocrine Society clinical practice
guidelines on evaluation, treatment and prevention of
Table 1 Socio-demographic factors and clinical










Gender Male 146 56.2
Gender 114 43.8
Place of residence Rural 77 29.6
Urban 183 70.4
Level of education No formal
education
18 6.9
Primary level 168 64.6
Secondary level 54 20.8
Tertiary level 20 7.7
Occupation Unemployed 58 22.3
Self employed 34 13.1
Unskilled 147 56.5
Skilled 21 8.1
Smoking status Former smokers 66 25.4
Non smokers 194 74.6
HIV infection Positive 208 80
History of TB treatment No 207 79.6
Karnofsky score <70% 132 50.8
Category of TB PTB 197 75.8
Body mass index <18.5 kg/m2 181 69.6
Mean (SD)-17.4 (2.5)
Dietary intake of fish
and milk
Once weekly 152 58.5
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deficiency, severe vitamin D deficiency, very severe
vitamin D deficiency, vitamin D insufficiency and normal
vitamin D levels were defined as serum 25(OH) D concen-
trations ≤ 20 ng/ml, < 10 ng/ml, <5 ng/ml, 21–29 ng\ml
and ≥ 30 ng/ml respectively. Hypoalbuminemia was de-
fined as a total serum albumin level of < 35 g/L while hypo-
calcaemia as serum calcium concentration corrected for
albumin < 9 mg/dl.
Ethical consideration
The study was approved by the department of In-
ternal Medicine, Makerere College of Health Sciences and
Makerere University School of Medicine research and eth-
ics committee. All patients gave informed consent prior to
enrolment into the study.
Results
Socio-demographic, clinical and laboratory characteristics
of the patients
Of the 260 study participants enrolled, majority were
male (146, 56.2%) and < 35 years (154, 59.2%). The mean
(SD) age of the study participants was 34.7 (9.5) years.
Two hundred eight participants (80%) were HIV sero
positive and these had a median CD4 of 68(IQR 17–165).
One hundred eighty one participants (69.6%) were under-
weight with a BMI of < 18.5 kg/m2. The mean BMI and
median haemoglobin level of the study participants was
17.35 (SD 2.51) and 8.9 g/dl (IQR 7.2-10.95) respectively.
Hypoalbuminemia and hypocalcaemia corrected for albu-
min was present in 234 (90%) and 135 (52%) patients re-
spectively. None of the enrolled study participants was on
treatment with anti TB drugs, corticosteroids, anti convul-
sants or any vitamin supplementation (Tables 1 and 2).
Prevalence of vitamin D deficiency among the patients
Vitamin D deficiency was present among 115 patients
(44.2%). Severe and very severe vitamin D deficiency
were noted among 35 (13.5%) and 11 (4.2%) participants
respectively. Sixty one (23.5%) and 84 (32.3%) patients
had vitamin D insufficiency and normal vitamin D levels
respectively. The median (IQR) vitamin D concentration
in ng/ml was 22.55 (14.59-33.31).
Vitamin D deficiency was noted to be more common
among patients with hypocalcaemia corrected for albu-
min concentration (67%), HIV co-infection (82.6%), CD4
counts < 200 cells/μl (83.2%), anemia (86.1%) and hypo-
albuminemia (97.4%).
Discussion
In this study, we report a prevalence of vitamin D
deficiency of 44.2% among 260 hospitalised adult pa-
tients with a confirmed diagnosis of TB at Mulago hos-
pital in Uganda.This demonstrates that vitamin D deficiency is highly
prevalent among admitted adult TB patients in Uganda.
These findings are congruent with what has been docu-
mented in other published African studies among TB
patients [5-9].
The high prevalence of vitamin D deficiency noted
among our study population could be probably due to
the inadequate dietary intake as reflected by the high
frequency of hypoalbuminemia (90%) and low BMI
(69.6%) among the study participants. In this study, we
did not perform a very comprehensive dietary or nutri-
tional assessment. However, majority of the study partic-
ipants (58.5%) gave a self report of at least once weekly
intake of vitamin D fortified milk and fish which are
both rich in vitamin D.
Varying prevalence of vitamin D deficiency has been
reported among TB patients in Africa. These disparities
could be explained by the varying study definitions of











§ALT level (U/L) Median
(IQR)-11 (6–19)
≥80 9 3.5
δ ALP level (U/L) Median
(IQR)-113 (79–183.5)
≥129 109 41.9
Hb** level (g/dl) Median
(IQR)-8.9 (7.2-10.95)
<12 212 81.5
Mean Cell Volume, fl <80 131 50.4
Parathyroid hormone (pg/ml) ≥65 6 2.3




δ ALP- Alkaline phosphatase.
**Hb-Haemoglobin.
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used for measurement of vitamin D concentrations, vary-
ing location in terms of latitude of the study sites,
seasonal variations, varying dietary habits and fre-
quencies of other co-morbidities among the respective
study participants.
The highest prevalence of vitamin D deficiency in
Africa has been documented by studies done in South
Africa (62.7%) [9] and Malawi (42.2%) [7]. The preva-
lence of vitamin D deficiency reported in our study is
comparable to that noted in the Malawian study. Both
studies used a similar technique of measuring serum
vitamin D concentrations (the electrochemilumniscence
immunoassay) and had a comparable prevalence of HIV
co-infection among the study participants.
A relatively higher prevalence of 62.7% was docu-
mented in a study among a cohort of black patients with
active TB done in Cape Town, South Africa [9]. This
varying finding with our study could be explained by the
differences in sunshine exposure due to the varying lati-
tudes and the seasonal variations in South Africa. Cape
Town is located on latitude 33°55´South while Kampala
is near the equator with plenty of regular sunshine all
year round.
Conversely, studies done in the western part of
Uganda [5], Guinea Bissau [6] and Mwanza in Tanzania [8]
have reported lower prevalence of vitamin D deficiency
among TB patients of 7%, 8.5% and 10.6% respectively
compared to ours. A lower prevalence of HIV co-infection
(47.2%) in Tanzania, reflecting a better overall health status
and the increased consumption of fish among the study
participants in Tanzania and Guinea Bissau could explain
the lower prevalence of vitamin D deficiency reported fromthese two settings. A different operational definition for
vitamin D deficiency of < 12 ng/ml as per the United States
Institute of Medicine guidelines [14] was used in the Ugan-
dan study hence the difference in the prevalence.
Increasing age was found to be independently associ-
ated with vitamin D deficiency in our study. This finding
has not been noted in other published African studies.
Vitamin D deficiency was noted to be more prevalent in
patients with hypoalbuminemia (97.4%), anemia (86.1%),
HIV co-infected patients with CD4 count <200cells/mm3
(83.2%) and hypocalcemia corrected for serum albumin
levels (67%).
In another Ugandan study [5] and a South African study
[9], vitamin D deficiency were associated with BMI. Studies
from Guinea Bissau [6] and South Africa [9] also noted
an independent association between hypovitaminosis D
and ethnicity (Fula ethnic group) and seasonal varia-
tions respectively.
Our study also demonstrated a very low prevalence of
secondary hyperparathyroidism of 2.6% among study
participants with vitamin D deficiency (2.3% among all
study participants). Secondary hyperparathyroidism is
invariably associated with vitamin D deficiency [12]. There
is a paucity of information on the correlation between
parathyroid hormone and vitamin D concentrations among
African TB patients.
The probable explanation of the observed low preva-
lence of hyperparathyroidism in this study is presence
of hypomagnesaemia induced functional hypoparathyr-
oidism commonly seen among chronically ill patients.
Hypomagnesaemia results mainly from chronic malnu-
trition, malabsorption due to enteropathy and chronic
diarrhea [15,16]. However, we did not measure magne-
sium concentrations in this study.
Study limitations
We used an electrochemilumniscence immunoassay
which has been shown to underestimate or overestimate
vitamin D concentrations. The liquid chromatography-
tandem mass spectrometry method of vitamin D measure-
ment which is regarded the most sensitive and accurate is
not available in the country [16].
Although we controlled for some of the confounding
factors, there is a possibility that we did not control for
all possible confounding factors.
Given that this was a cross sectional study, the
temporality between TB and VDD cannot be clearly
established.
We were unable to assess the dietary intake of vitamin D
and exclude some causes of vitamin D deficiency like
nephrotic syndrome, chronic pancreatitis and other causes
of malabsorption syndrome among the study participants.
However, no study participant had clinical features suggest-
ive of these disorders.
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since it was a hospital based study that recruited only
admitted patients that are frequently critically ill.
Conclusion
Despite all year round presence of abundant sunshine,
vitamin D deficiency is highly prevalent among hospital-
ized adult TB patients in Uganda. Further randomized
clinical trials to evaluate the effect of oral vitamin D re-
placement therapy on clinical outcomes and treatment
of TB among Ugandan TB patients could help assess a
fundamental role of vitamin D in TB.
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